The company in question is, Sanofi (NYSE:SNY) currently with a stock price of 37.35 (-1.06% today). The market cap for Sanofi is 95680.99, and is in the sector Healthcare, and Drug Manufacturers – Major industry. The target price for Sanofi is 51.67. Currently Sanofi is trading with a P/E of 21.27, and a forward P/E of 12.6. Average volume for Sanofi is 2222.82 and so far today it is 2023200.
Performance in the last year for Sanofi has been -22.99%. For EPS growth, Sanofi has seen a growth of 4.10%, and is looking to grow in the next year to -2.79%. More long term stats show that EPS growth has been -4.40% over the last five years and could be 6.60% for the next five years. Sanofi has seen sales growth quarter over quarter at *TBA, with EPS growth quarter over quarter at *TBA. The 20-day simple moving average is -4.17%, with the 200-day simple moving average coming to -5.76%.
Since the IPO date for Sanofi on the 7/1/2002, Sanofi has seen performance year to date to be -8.74%. With Sanofi trading at 37.35, the dividend yield is 4.44%, and the EPS is 1.76.
So could Sanofi, be undervalued? Well as said before P/E is 21.27. The PEG is 3.22, P/S is 2.54 and the P/B is at 1.59. The P/cash is *TBA, with P/free cash flow at *TBA.
Sanofi ability to deal with debt shows that the current ratio is *TBA, and the quick ratio is *TBA. This is with long term debt/equity at *TBA, and total debt/equity at *TBA.
In terms of margins, Sanofi has a gross margin of 68.90%, an operating margin of *TBA and a profit margin of *TBA.Payout ratio for Sanofi is *TBA. Return on assets come to *TBA with return on investment coming to 6.50%.
Insider ownership for Sanofi, is at 16.40% and institutional ownership comes to 10.20%. Outstanding shares are at 2561.74. While shares float is 2304.29. The float short is currently 0.15%, and short ratio is 1.5.